Trial Outcomes & Findings for Regional Data Exchange to Improve Medication Safety (NCT NCT01239121)
NCT ID: NCT01239121
Last Updated: 2016-08-15
Results Overview
Rating of potential for harm to patient from hospital medication discrepancies by record review. Minimum=0 Maximum=no maximum. Higher values represent increased detection of medication discrepancies. Although medication discrepancies are undesirable, increasing their detection might facilitate prevention of adverse drug events.
COMPLETED
NA
402 participants
During hospital stay and up to 1 month after hospital discharge
2016-08-15
Participant Flow
Participant milestones
| Measure |
HIE-Enhanced Medication Reconciliation
Health Information Exchange (HIE)-Enhanced Medication Reconciliation for veterans admitted to James J Peters VA hospital units 6B, 7B, 7C, and 8B (each unit crossing over between intervention and control every 3-4 months)
HIE-Enhanced Medication Reconciliation: Medication reconciliation enhanced by regional health information exchange, implemented by a pharmacist
|
Optimal Medication Reconciliation Without HIE
Optimal Medication Reconciliation without Health Information Exchange (HIE) for veterans admitted to James J Peters VA hospital units 6B, 7B, 7C, and 8B (each unit crossing over between intervention and control every 3-4 months)
Optimal Medication Reconciliation without HIE: Medication reconciliation implemented by a pharmacist without regional health information exchange
|
Pilot HIE-Enhanced Outpatient Medication Reconciliation
Health Information Exchange (HIE)-Enhanced Medication Reconciliation for veterans seen as outpatients in Geriatrics Primary care clinic
HIE-Enhanced Medication Reconciliation: Medication reconciliation enhanced by regional health information exchange, implemented by a pharmacist
|
|---|---|---|---|
|
Overall Study
STARTED
|
188
|
199
|
15
|
|
Overall Study
COMPLETED
|
186
|
195
|
15
|
|
Overall Study
NOT COMPLETED
|
2
|
4
|
0
|
Reasons for withdrawal
| Measure |
HIE-Enhanced Medication Reconciliation
Health Information Exchange (HIE)-Enhanced Medication Reconciliation for veterans admitted to James J Peters VA hospital units 6B, 7B, 7C, and 8B (each unit crossing over between intervention and control every 3-4 months)
HIE-Enhanced Medication Reconciliation: Medication reconciliation enhanced by regional health information exchange, implemented by a pharmacist
|
Optimal Medication Reconciliation Without HIE
Optimal Medication Reconciliation without Health Information Exchange (HIE) for veterans admitted to James J Peters VA hospital units 6B, 7B, 7C, and 8B (each unit crossing over between intervention and control every 3-4 months)
Optimal Medication Reconciliation without HIE: Medication reconciliation implemented by a pharmacist without regional health information exchange
|
Pilot HIE-Enhanced Outpatient Medication Reconciliation
Health Information Exchange (HIE)-Enhanced Medication Reconciliation for veterans seen as outpatients in Geriatrics Primary care clinic
HIE-Enhanced Medication Reconciliation: Medication reconciliation enhanced by regional health information exchange, implemented by a pharmacist
|
|---|---|---|---|
|
Overall Study
Withdrawal by Subject
|
2
|
4
|
0
|
Baseline Characteristics
Regional Data Exchange to Improve Medication Safety
Baseline characteristics by cohort
| Measure |
HIE-Enhanced Medication Reconciliation
n=186 Participants
Health Information Exchange (HIE)-Enhanced Medication Reconciliation for veterans admitted to James J Peters VA hospital units 6B, 7B, 7C, and 8B (each unit crossing over between intervention and control every 3-4 months)
HIE-Enhanced Medication Reconciliation: Medication reconciliation enhanced by regional health information exchange, implemented by a pharmacist
|
Optimal Medication Reconciliation Without HIE
n=195 Participants
Optimal Medication Reconciliation without Health Information Exchange (HIE) for veterans admitted to James J Peters VA hospital units 6B, 7B, 7C, and 8B (each unit crossing over between intervention and control every 3-4 months)
Optimal Medication Reconciliation without HIE: Medication reconciliation implemented by a pharmacist without regional health information exchange
|
Pilot HIE-Enhanced Outpatient Medication Reconciliation
n=15 Participants
Health Information Exchange (HIE)-Enhanced Medication Reconciliation for veterans seen as outpatients in Geriatrics Primary care clinic
HIE-Enhanced Medication Reconciliation: Medication reconciliation enhanced by regional health information exchange, implemented by a pharmacist
|
Total
n=396 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Continuous
|
59.7 years
STANDARD_DEVIATION 14.4 • n=5 Participants
|
60.8 years
STANDARD_DEVIATION 14.5 • n=7 Participants
|
86.4 years
STANDARD_DEVIATION 6.8 • n=5 Participants
|
60.5 years
STANDARD_DEVIATION 14.1 • n=4 Participants
|
|
Sex: Female, Male
Female
|
6 Participants
n=5 Participants
|
7 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
13 Participants
n=4 Participants
|
|
Sex: Female, Male
Male
|
180 Participants
n=5 Participants
|
188 Participants
n=7 Participants
|
15 Participants
n=5 Participants
|
383 Participants
n=4 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
44 Participants
n=5 Participants
|
55 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
100 Participants
n=4 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
138 Participants
n=5 Participants
|
138 Participants
n=7 Participants
|
11 Participants
n=5 Participants
|
287 Participants
n=4 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
4 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
9 Participants
n=4 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
1 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
4 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Black or African American
|
121 Participants
n=5 Participants
|
120 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
245 Participants
n=4 Participants
|
|
Race (NIH/OMB)
White
|
57 Participants
n=5 Participants
|
64 Participants
n=7 Participants
|
9 Participants
n=5 Participants
|
130 Participants
n=4 Participants
|
|
Race (NIH/OMB)
More than one race
|
1 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
5 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
6 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
12 Participants
n=4 Participants
|
|
Region of Enrollment
United States
|
186 participants
n=5 Participants
|
195 participants
n=7 Participants
|
15 participants
n=5 Participants
|
396 participants
n=4 Participants
|
PRIMARY outcome
Timeframe: During hospital stay and up to 1 month after hospital dischargePopulation: Outcome not ascertained in the third arm because those participants were not hospitalized.
Rating of potential for harm to patient from hospital medication discrepancies by record review. Minimum=0 Maximum=no maximum. Higher values represent increased detection of medication discrepancies. Although medication discrepancies are undesirable, increasing their detection might facilitate prevention of adverse drug events.
Outcome measures
| Measure |
HIE-Enhanced Medication Reconciliation
n=186 Participants
Health Information Exchange (HIE)-Enhanced Medication Reconciliation for veterans admitted to James J Peters VA hospital units 6B, 7B, 7C, and 8B (each unit crossing over between intervention and control every 3-4 months)
HIE-Enhanced Medication Reconciliation: Medication reconciliation enhanced by regional health information exchange, implemented by a pharmacist
|
Optimal Medication Reconciliation Without HIE
n=195 Participants
Optimal Medication Reconciliation without Health Information Exchange (HIE) for veterans admitted to James J Peters VA hospital units 6B, 7B, 7C, and 8B (each unit crossing over between intervention and control every 3-4 months)
Optimal Medication Reconciliation without HIE: Medication reconciliation implemented by a pharmacist without regional health information exchange
|
Pilot HIE-Enhanced Outpatient Medication Reconciliation
Health Information Exchange (HIE)-Enhanced Medication Reconciliation for veterans seen as outpatients in Geriatrics Primary care clinic
HIE-Enhanced Medication Reconciliation: Medication reconciliation enhanced by regional health information exchange, implemented by a pharmacist
|
|---|---|---|---|
|
Transition Drug Risk
|
6.4 units: risk-weighted discrepancies
Standard Deviation 5.9
|
5.8 units: risk-weighted discrepancies
Standard Deviation 5.0
|
—
|
SECONDARY outcome
Timeframe: During hospital stay and up to 1 month after hospital dischargePopulation: Outcome not ascertained in the third arm because those participants were not hospitalized.
Actual harm to patient from hospital medication discrepancies by record review
Outcome measures
| Measure |
HIE-Enhanced Medication Reconciliation
n=186 Participants
Health Information Exchange (HIE)-Enhanced Medication Reconciliation for veterans admitted to James J Peters VA hospital units 6B, 7B, 7C, and 8B (each unit crossing over between intervention and control every 3-4 months)
HIE-Enhanced Medication Reconciliation: Medication reconciliation enhanced by regional health information exchange, implemented by a pharmacist
|
Optimal Medication Reconciliation Without HIE
n=195 Participants
Optimal Medication Reconciliation without Health Information Exchange (HIE) for veterans admitted to James J Peters VA hospital units 6B, 7B, 7C, and 8B (each unit crossing over between intervention and control every 3-4 months)
Optimal Medication Reconciliation without HIE: Medication reconciliation implemented by a pharmacist without regional health information exchange
|
Pilot HIE-Enhanced Outpatient Medication Reconciliation
Health Information Exchange (HIE)-Enhanced Medication Reconciliation for veterans seen as outpatients in Geriatrics Primary care clinic
HIE-Enhanced Medication Reconciliation: Medication reconciliation enhanced by regional health information exchange, implemented by a pharmacist
|
|---|---|---|---|
|
Adverse Drug Events
|
19 participants
|
18 participants
|
—
|
SECONDARY outcome
Timeframe: Up to 1 month after hospital dischargePopulation: For this outcome 66 and 87 participants unable to be reached by telephone in first and second arms, respectively. Outcome not ascertained in the third arm because those participants were not hospitalized.
Patient's self-report of medication-related symptoms by telephone questionnaire
Outcome measures
| Measure |
HIE-Enhanced Medication Reconciliation
n=120 Participants
Health Information Exchange (HIE)-Enhanced Medication Reconciliation for veterans admitted to James J Peters VA hospital units 6B, 7B, 7C, and 8B (each unit crossing over between intervention and control every 3-4 months)
HIE-Enhanced Medication Reconciliation: Medication reconciliation enhanced by regional health information exchange, implemented by a pharmacist
|
Optimal Medication Reconciliation Without HIE
n=108 Participants
Optimal Medication Reconciliation without Health Information Exchange (HIE) for veterans admitted to James J Peters VA hospital units 6B, 7B, 7C, and 8B (each unit crossing over between intervention and control every 3-4 months)
Optimal Medication Reconciliation without HIE: Medication reconciliation implemented by a pharmacist without regional health information exchange
|
Pilot HIE-Enhanced Outpatient Medication Reconciliation
Health Information Exchange (HIE)-Enhanced Medication Reconciliation for veterans seen as outpatients in Geriatrics Primary care clinic
HIE-Enhanced Medication Reconciliation: Medication reconciliation enhanced by regional health information exchange, implemented by a pharmacist
|
|---|---|---|---|
|
Medication-related Symptoms
|
24 participants
|
21 participants
|
—
|
Adverse Events
HIE-Enhanced Medication Reconciliation
Optimal Medication Reconciliation Without HIE
Pilot HIE-Enhanced Outpatient Medication Reconciliation
Serious adverse events
| Measure |
HIE-Enhanced Medication Reconciliation
n=120 participants at risk;n=186 participants at risk
Health Information Exchange (HIE)-Enhanced Medication Reconciliation for veterans admitted to James J Peters VA hospital units 6B, 7B, 7C, and 8B (each unit crossing over between intervention and control every 3-4 months)
HIE-Enhanced Medication Reconciliation: Medication reconciliation enhanced by regional health information exchange, implemented by a pharmacist
|
Optimal Medication Reconciliation Without HIE
n=108 participants at risk;n=195 participants at risk
Optimal Medication Reconciliation without Health Information Exchange (HIE) for veterans admitted to James J Peters VA hospital units 6B, 7B, 7C, and 8B (each unit crossing over between intervention and control every 3-4 months)
Optimal Medication Reconciliation without HIE: Medication reconciliation implemented by a pharmacist without regional health information exchange
|
Pilot HIE-Enhanced Outpatient Medication Reconciliation
n=15 participants at risk
Health Information Exchange (HIE)-Enhanced Medication Reconciliation for veterans seen as outpatients in Geriatrics Primary care clinic
HIE-Enhanced Medication Reconciliation: Medication reconciliation enhanced by regional health information exchange, implemented by a pharmacist
|
|---|---|---|---|
|
Investigations
Hospital Readmission
|
21.0%
39/186 • Participants were followed for adverse events during the hospital stay (up to a maximum of 30 days) and up to 30 days after hospital discharge.
|
18.5%
36/195 • Participants were followed for adverse events during the hospital stay (up to a maximum of 30 days) and up to 30 days after hospital discharge.
|
0.00%
0/15 • Participants were followed for adverse events during the hospital stay (up to a maximum of 30 days) and up to 30 days after hospital discharge.
|
Other adverse events
| Measure |
HIE-Enhanced Medication Reconciliation
n=120 participants at risk;n=186 participants at risk
Health Information Exchange (HIE)-Enhanced Medication Reconciliation for veterans admitted to James J Peters VA hospital units 6B, 7B, 7C, and 8B (each unit crossing over between intervention and control every 3-4 months)
HIE-Enhanced Medication Reconciliation: Medication reconciliation enhanced by regional health information exchange, implemented by a pharmacist
|
Optimal Medication Reconciliation Without HIE
n=108 participants at risk;n=195 participants at risk
Optimal Medication Reconciliation without Health Information Exchange (HIE) for veterans admitted to James J Peters VA hospital units 6B, 7B, 7C, and 8B (each unit crossing over between intervention and control every 3-4 months)
Optimal Medication Reconciliation without HIE: Medication reconciliation implemented by a pharmacist without regional health information exchange
|
Pilot HIE-Enhanced Outpatient Medication Reconciliation
n=15 participants at risk
Health Information Exchange (HIE)-Enhanced Medication Reconciliation for veterans seen as outpatients in Geriatrics Primary care clinic
HIE-Enhanced Medication Reconciliation: Medication reconciliation enhanced by regional health information exchange, implemented by a pharmacist
|
|---|---|---|---|
|
Investigations
Medication-related symptoms
|
20.0%
24/120 • Participants were followed for adverse events during the hospital stay (up to a maximum of 30 days) and up to 30 days after hospital discharge.
|
19.4%
21/108 • Participants were followed for adverse events during the hospital stay (up to a maximum of 30 days) and up to 30 days after hospital discharge.
|
—
0/0 • Participants were followed for adverse events during the hospital stay (up to a maximum of 30 days) and up to 30 days after hospital discharge.
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place